BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28081946)

  • 1. [Hepatocellular carcinoma surveillance].
    Costentin C
    Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for hepatocellular carcinoma: how can we do better?
    Hassett M; Yopp AC; Singal AG
    Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
    Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
    Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
    J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
    Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound surveillance for hepatocellular carcinoma: service evaluation of a radiology-led recall system in a tertiary-referral centre for liver diseases in the UK.
    Farrell C; Halpen A; Cross TJ; Richardson PD; Johnson P; Joekes EC
    Clin Radiol; 2017 Apr; 72(4):338.e11-338.e17. PubMed ID: 28041651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
    Trinchet JC; Nahon P; Ganne-Carrie N
    Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
    Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients.
    Henrion J; Libon E; De Maeght S; Schapira M; Ghilain JM; Maisin JM; Heller FR
    Acta Gastroenterol Belg; 2000; 63(1):5-9. PubMed ID: 10907311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients.
    Merchante N; Figueruela B; Rodríguez-Fernández M; Rodríguez-Arrondo F; Revollo B; Ibarra S; Galindo MJ; Merino E; Montero M; Téllez F; García-Deltoro M; Rivero-Juárez A; Delgado-Fernández M; Ríos-Villegas MJ; Aguirrebengoa K; García MA; Portu J; Vera-Méndez FJ; Villalobos M; Mínguez C; De Los Santos I; López-Ruz MA; Omar M; Galera C; Macias J; Pineda JA;
    AIDS; 2019 Feb; 33(2):269-278. PubMed ID: 30325782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: a retrospective case-control study.
    De Santis A; Iegri C; Kondili L; Riggio O; Salvatori FM; Catalano C; Di Martino M; Bassanelli C; Lupo M; Lucatelli P; Attili AF
    Dig Liver Dis; 2014 Aug; 46(8):726-30. PubMed ID: 24893685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma detected by regular surveillance: Does timely confirmation of diagnosis matter?
    Yeh JH; Hung CH; Wang JH; Kuo YH; Tai WC; Lu SN
    Dig Liver Dis; 2016 Jun; 48(6):661-6. PubMed ID: 26992848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
    Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
    J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
    Lange N; Dufour JF
    Dig Dis Sci; 2019 Apr; 64(4):903-909. PubMed ID: 30863952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
    Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
    Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
    JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma surveillance with ultrasound-cost-effectiveness, high-risk populations, uptake.
    Ronot M; Pommier R; Dioguardi Burgio M; Purcell Y; Nahon P; Vilgrain V
    Br J Radiol; 2018 Oct; 91(1090):20170436. PubMed ID: 29446324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.